Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer
about
Role of pregnane X receptor in chemotherapeutic treatmentVascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide.Cystitis increases colorectal afferent sensitivity in the mouse.Treatment of vasculitis.Depletion of circulating cyst(e)ine by oral and intravenous mesnaDrug-induced acute kidney injury in childrenDo antioxidants interfere with radiation therapy for cancer?Urological implications of cyclophosphamide and ifosfamide.Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models.Use of precision-cut renal cortical slices in nephrotoxicity studies.Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.In vitro and in silico evaluation of NF-κB targeted costunolide action on estrogen receptor-negative breast cancer cells--a comparison with normal breast cells.Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.A tubule cell model for ifosfamide nephrotoxicity.Pharmacokinetic study of perioperative intravenous Ifosfamide.Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.Self-assembling drugs: a new approach to biochemical modulation in cancer chemotherapy.The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactionsDownregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.The cytogenetic action of ifosfamide, mesna, and their combination on peripheral rabbit lymphocytes: an in vivo/in vitro cytogenetic study.Ifosfamide extravasation.Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.Novel Therapies for Acute Kidney Injury.Stimulation of respiration by methylene blue in rat liver mitochondria.New investigations into the stability of Mesna using LC-MS/MS and NMR.Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.Interleukin-4 Modulates the Inflammatory Response in Ifosfamide-Induced Hemorrhagic Cystitis
P2860
Q26827398-9A5519EF-2D7C-48F3-9C90-519DA9A6AE48Q30890450-D9BAEFE5-3C29-4BCF-98EE-AE8A64435BFFQ33771699-DA456B16-F3BA-498F-ABED-2DDE54A3E743Q34403507-451E5F0B-73DC-4DB8-A16A-60E29536522EQ35976646-AD96179E-F68A-4010-84E5-C0B13A65CB92Q36125552-DBC7A246-F30D-48B1-A6C0-7FC5EDF4BEF9Q36924702-D5285ADD-F6A3-4BDB-A949-A02EFCF93D44Q37264407-E5DF7D1B-0094-4FD4-8179-F51436B3689EQ37283967-B89789CB-A21A-46C9-843E-C90D8BA390A1Q38048918-65E8AC4E-1086-41C5-B0E1-35EA78D45ADFQ38154859-1FCC901C-4892-47E1-9925-3413BC0766D0Q38245322-29F6EEDE-DBFC-4757-9280-0F589BA0C72BQ39004090-33B7E08A-226C-406D-8BC5-CB1BD67B6DDFQ40355100-F3CBD448-0DE3-4B7A-B097-36D621FE3E44Q40392443-345C5659-F709-4FAB-B083-756221C7C3A4Q40583827-D0715C8E-317F-4CF9-939D-E6F17DD5F02EQ40620300-8F5967B1-6DE3-4FD4-BB29-98EE6D9026DBQ40666278-3B2F8C5B-C2B3-4AC2-AD0D-1F858290D085Q40726389-0E2B34F8-6010-47BC-841C-8CA385365D8CQ41030442-DE92984A-D8F5-48CE-83C6-CCDD2D23CA6FQ41736628-F7CEE8CD-6455-421C-B7FE-0219B0D86C03Q42154761-A2EF6476-FE11-4F10-8378-B59F8A240B40Q42280674-7DA3329A-EF70-4E9E-B919-05D4111AA87CQ46090646-130C7006-13AB-43DD-AFA4-15942AAD7159Q47099705-D1AFB14A-D69B-4039-8A7E-29B63DB576CCQ50527505-B61B572F-1184-4565-8BE7-ED82BC3075E3Q51645023-9FC13DB1-9243-437C-9F0C-A37F95DE904CQ52915030-E3F62A5C-0D34-4E4B-9AEA-A18325CBA116Q57450695-7AF35462-9838-4809-967F-F01178BF32E8
P2860
Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@ast
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@en
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@nl
type
label
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@ast
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@en
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@nl
prefLabel
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@ast
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@en
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@nl
P2093
P1433
P1476
Ifosfamide/mesna. A review of ...... therapeutic efficacy in cancer
@en
P2093
K L Dechant
T Pilkington
P304
P356
10.2165/00003495-199142030-00006
P407
P577
1991-09-01T00:00:00Z
P6179
1005265704